$2.43
-0.035-1.42%
Last update: Nov 10, 5:04 PM
Sana Biotechnology Inc
SANANASDAQ
Sana Biotechnology fell 40.2% from $4.12 to $2.47, behind the S&P 500's +10.0%. Its worst day was Feb 5 (−12.8%), and its low came Oct 16 at $2.27.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Sana Biotechnology shares rose 14.5%, while the S&P 500 rose 0.7%.
+14.5% · S&P 500 +0.7%
Sana Biotechnology closed at its highest level of the year, 25.7% above where the year started.
Story events cover the past 12 months · Times ET
+15.9%, the year's best day · S&P 500 +0.1%
Sana Biotechnology shares fell 12.8%, while the S&P 500 fell 1.2%.
−12.8%, the year's worst day · S&P 500 −1.2%
EPS of $-0.16 missed the $-0.13 estimate on $0.00 revenue.
−2.8% · S&P 500 +0.7%
EPS of $-0.14 beat the $-0.15 estimate on $0.00 revenue.
−8.4% · S&P 500 −0.2%
Sana Biotechnology shares rose 12.6%, while the S&P 500 fell 0.1%.
+12.6% · S&P 500 −0.1%
EPS of $-0.13 beat the $-0.13 estimate on $0.00 revenue.
+5.0% · S&P 500 −0.3%
Sana Biotechnology shares rose 12.9%, while the S&P 500 rose 0.2%.
+12.9% · S&P 500 +0.2%
Sana Biotechnology closed at its lowest level of the year, 44.9% below where the year started.
−8.3% · S&P 500 −1.1%
EPS of $-0.14 beat the $-0.14 estimate on $0.00 revenue.
+1.3% · S&P 500 +0.3%
Where it ended: a close of $2.46 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 2, 2027 (EPS est. $-0.19).
Nothing in the past 12 months.
All SANA dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SANA and SPY from Benzinga historical bars. Not investment advice.
